Anti-KLH Polyclonal Antibody

Product Specifications

Background

Denosumab with trade name Prolia, is an FDA-approved drug for the treatment of patients with osteoporosis, treatment-induced bone loss, metastases to bone, and giant cell tumor of bone. Denosumab is a fully human monoclonal antibody that works as a RANK ligand (RANKL) inhibitor. Denosumab can bind RANKL, preventing RANKL from activating RANK, its receptor on the osteoclast surface.

Host

Rabbit

Immunogen

Native Keyhole Limpet Hemocyanin (KLH) .

Target

Keyhole Limpet Hemocyanin, KLH

Clonality

Polyclonal

Applications

ELISA, WB

Purification

Purified by antigen affinity column.

Form

Liquid

Buffer

0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.

Storage Conditions

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.